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Introduction
Virulence associated with several Gram-negative bacterial patho-
gens requires the translocation of “effector” proteins from bacte-
ria into host cells through a dedicated protein translocation 
apparatus termed the type III secretion system (TTSS) (Galan 
and Collmer, 1999; Cornelis and Van Gijsegem, 2000). Many 
bacterial effector proteins possess a specialized activity required 
to limit anti-microbial immune response and promote bacterial 
growth and dissemination during pathogenesis. We are particu-
larly interested in the mechanisms of type III effector proteins 
found in the attaching and effacing (A/E) pathogen group includ-
ing enteropathogenic Escherichia coli (EPEC) and its close rela-
tives, enterohaemorrhagic Escherichia coli (EHEC 0157:H7) 
and Citrobacter rodentium that cause severe gastrointestinal 
  disease. Although the coordinated actions of several type III 
effector proteins including Tir, Map, EspF, EspG, EspH, EspI, 
EspJ, EspK, EspZ, and NleA-F are required for virulence asso-
ciated with A/E pathogens, the biochemical activities of most 
effectors are poorly defi  ned.
Microbial pathogens may hijack the actin cytoskeleton 
machinery to perform a variety of functions that include actin-
based motility, cellular invasion, and intracellular traffi  cking 
through the endocytic pathway (Gruenheid and Finlay, 2003). 
A key regulator of the actin cytoskeleton is neuronal Wiskott-
Aldrich syndrome protein (N-WASP), a eukaryotic protein that 
initiates actin fi  lament branching and assembly through the 
  direct activation of the Arp2/3 complex. Due to its critical role 
in this process, N-WASP is tightly regulated by upstream sig-
nals including phospholipids (PIP2), the small G-protein Cdc42, 
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acterial toxins and effector proteins hijack eukary-
otic enzymes that are spatially localized and display 
rapid signaling kinetics. However, the molecular mech-
anisms by which virulence factors engage highly dynamic 
substrates in the host cell environment are poorly under-
stood. Here, we demonstrate that the enteropathogenic 
Escherichia coli (EPEC) type III effector protein EspF 
nucleates a multiprotein signaling complex composed of 
eukaryotic sorting nexin 9 (SNX9) and neuronal Wiskott-
Aldrich syndrome protein (N-WASP). We demonstrate 
that a speciﬁ  c and high afﬁ  nity association between EspF 
and SNX9 induces membrane remodeling in host cells. 
These membrane-remodeling events are directly coupled to 
N-WASP/Arp2/3–mediated actin nucleation. In addition 
to providing a biochemical mechanism of EspF function, 
we ﬁ  nd that EspF dynamically localizes to membrane-
  trafﬁ  cking organelles in a spatiotemporal pattern that 
  correlates with SNX9 and N-WASP activity in living cells. 
Thus, our ﬁ   ndings suggest that the EspF-dependent as-
sembly of SNX9 and N-WASP represents a novel form of 
signaling mimicry used to promote EPEC pathogenesis 
and gastrointestinal disease.
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and Src homology-3 (SH3) adaptor proteins (Higgs and Pollard, 
2001). Recent work also indicates that N-WASP is intimately asso-
ciated with mechanisms of endocytosis (Merrifi  eld et al., 2004; 
Benesch et al., 2005; Kaksonen et al., 2006), a cellular process 
required for the uptake of extracellular components including 
microbial pathogens and viruses (Veiga and Cossart, 2006).
Membrane remodeling during endocytosis requires the 
spatiotemporal coordination of several phospholipids and F-actin 
binding proteins (Merrifi  eld et al., 2002; Kaksonen et al., 2005). 
As a specifi  c example, sorting nexin 9 (SNX9) is dynamically 
recruited to clathrin-coated pits (CCPs) at the late stages of 
  vesicle formation (Lundmark and Carlsson, 2003; Soulet et al., 
2005). Although the exact role of SNX9 is not well understood, 
its domain architecture suggests that it links the plasma mem-
brane to proteins associated with the cellular cortex. SNX9 pos-
sesses two lipid interaction domains, a phospholipid-binding 
module termed the phox (PX) domain followed by a putative 
Bin/Amphiphysin/Rvs (BAR) lipid-binding domain. Interest-
ingly, the BAR domain is a banana-shaped helical dimer that 
senses membrane curvature and can reconfi  gure lipid vesicles 
or sheets into membrane tubules (Peter et al., 2004). In addition to 
its lipid-binding properties, SNX9 also possesses an N-terminal 
Src homology-3 (SH3) protein interaction module that was 
recently shown to bind WASP (Badour et al., 2007) and to 
  functionally activate dynamin at CCPs (Soulet et al., 2005). Thus, 
SNX9 is uniquely suited to regulate the membrane/cytoskeletal 
interface during clathrin-mediated endocytosis.
In this paper, we found that the type III effector EspF co-
ordinates membrane remodeling and F-actin polymerization 
during EPEC pathogenesis. Similar to previous results (Marches 
et al., 2006), we found that EspF binds the SH3 domain of 
SNX9 and we further demonstrated that this interaction induces 
membrane remodeling, a phenotype that is functionally coupled 
to N-WASP–dependent actin polymerization in eukaryotic cells. 
EspF activated both SNX9 and N-WASP in a coordinated 
  spatiotemporal pattern at CCPs. Importantly, these data provide 
a molecular mechanism for EspF function in host cells and fur-
ther suggest that the dynamic interplay between bacterial type III 
effector proteins and eukaryotic signaling pathways is a critical 
aspect of host–pathogen interactions.
Results
Identiﬁ  cation of SNX9 and N-WASP 
as an EspF-binding protein
Database searches reveal that EspF orthologues are found in an 
A/E pathogen group that includes EPEC, EHEC 0157:H7, and 
Citrobacter rodentium (Fig. 1, A and B). EspF is composed of 
Figure 1.  The EPEC effector EspF binds both SNX9 and N-WASP. (A) Schematic of EspF proline-rich repeat (PRR) domains from EPEC, EHEC 0157:H7, and 
Citrobacter rodentium. SNX9 (blue) and putative N-WASP (orange) binding sites are shown. (B) Clustal alignment comparing each PRR domains of EspF 
from EPEC (EP), EHEC 0157:H7 (EH), and Citrobacter rodentium (CR) to those of EspFu/TccP (EH). GenBank accession no. is listed. The SNX9 binding site 
is highlighted in blue; and putative N-WASP binding residues are shown in orange. (C) Schematic of SNX9 showing the Src homology-3 (SH3), p47 oxidase 
(PHOX), and Bin-Amphiphysin-RVS (BAR) domains. The cDNA clone (residues 1–111) that interacts with EspF is indicated. (D) Schematic of N-WASP show-
ing the Enabled/VASP homology 1 (EVH1), the Cdc42/rac interactive binding (CRIB), the poly-proline (Proline), and the Verpolin/Coﬁ  lin/Acidic (VCA) domain. 
The cDNA clone (residues 200–258) that interacts with EspF is indicated.ESPF NUCLEATES A MEMBRANE-TRAFFICKING SIGNALING COMPLEX • ALTO ET AL. 1267
47 amino acid proline-rich repeats (PRRs) that are repeated sev-
eral times throughout the coding sequence. Although the repeat 
numbers vary amongst EspF orthologues in A/E pathogens, 
there are no cases where the PRR sequence is present as a single 
copy. In addition, EHEC 0157:H7 possesses a second PRR do-
main protein called EspFu/TccP that shares 35% homology 
with EspF, but has a distinct biological function (Campellone 
et al., 2004; Garmendia et al., 2004). To defi  ne eukaryotic binding 
partners we screened EspF against a mouse embryo cDNA 
library using the yeast two-hybrid system. Screening of 8 million 
yeast transformants yielded fi  ve positives. Two cDNAs encoded 
the SH3 domain of SNX9 (Fig. 1 C, residues 1–111) and 
the Cdc42/rac interactive binding (CRIB) domain of N-WASP 
(Fig. 1 D, residues 200–258).
EspF binds SNX9 through a highly evolved 
SH3 ligand motif
Our yeast two-hybrid clone spanned residues 1–111 of SNX9, 
a region encompassing its SH3 domain. This interaction was 
confi  rmed using [
35S]-methionine labeled SNX9 1–111 (SH3 
domain) and recombinant GST-EspF fusion protein, which se-
lectively interacted in pull-down assays (Fig. 2 A). Grb2, Nck1, 
and Nck2, three SH3 domain–containing proteins with broad 
ligand specifi  city, could not be copurifi  ed with EspF (Fig. 2 A). 
Similar binding specifi  city was also observed in vivo by co-
immunoprecipitation assays from transfected Hek293A cells. 
These data demonstrate that EspF interacts with full-length 
SNX9 but not Grb2, Nck1, or Nck2 in cells (Fig. 2 B).
In general the  300 SH3 domains in the human genome 
bind ligands with a canonical PxxP motif. It was surprising that 
only one SH3 protein was identifi  ed in our high coverage yeast 
two-hybrid screen. To better understand this apparent specifi  city, 
we used phage-displayed peptide libraries to explore the binding 
specifi  city profi  les of the SH3 domain of SNX9. The SH3 domain 
was screened against a library composed of 10
10 completely 
random dodecapeptides. After four rounds of affi  nity selec-
tion, 150 individual binding-phage were sequenced. Remarkably, 
only 13 unique peptides were identifi  ed from the 150 sequences, 
suggesting that SNX9 recognizes a highly conserved sequence 
motif (Fig. 2 C). Homology alignment was used to derive a 
SNX9 specifi  city profi  le in the form of a preferred binding motif 
(Fig. 2 C). Notably, the specifi  city profi  le confi  rmed that the 
SH3 domain recognizes multiple features of the ligand sequence; 
an arginine was invariant at the −3 position, alanine was pre-
ferred at the −1, and prolines were selected at the 0 and +3 
  positions of the PxxP motif. These data determine the preferred 
consensus SNX9 SH3 ligand motif as RxAPxxP.
Next, an in vitro–translated 
35S-SNX9 was used to screen 
a solid phase library containing peptides of 15-mer residues 
(offset every three residues) spanning amino acids 1–166 in 
EspF (Fig. 2 D). By overlaying 
35S-SNX9 onto the EspF peptide 
library, we found that the SH3 binding site in EspF was confi  ned 
Figure 2.  Identiﬁ  cation of motifs required for direct EspF and SNX9 interactions. (A) Glutathione-Sepharose pull-down with 10 μg of GST-EspF (residues 
48–206) mixed with the [
35S]-methionine proteins indicated (left diagram). Autoradiograph of GST pulldown (left) and of 1/20th input of 
35S-labeled 
NCK1, NCK2, SNX9 (residues 1–111), and GRB2 is shown (right). (B) HEK293A cells were cotransfected with EGFP-EspF and V5-tagged proteins indi-
cated (left diagram). Anti-GFP immunoprecipitations (IP) were probed by V5 immunoblot (IB) (left). Cell lysates were probed by V5 or GFP immunoblot to 
show input levels. (C) Logos plot of the SNX9 binding consensus sequence derived by phage display experiments (left). Alignment of 13 unique SNX9 bind-
ing sequences used to derive the consensus is shown. The invariant arginine (blue) and highly conserved residues (gray) are highlighted. (D) Peptide array 
analysis of the SNX9-binding sites on EspF. Top: diagram of EspF residues 1–166 used for the peptide scanning experiments. Middle: ultraviolet (UV) illumi-
nation shows the qualitative amount of each peptide synthesized (top). Bottom: solid-phase binding of 
35S-SNX9 to 15-mer EspF peptides was assessed by 
autoradiography. An alignment of EspF-binding peptides from two SNX9 binding series is shown. (E) Saturation binding curves were generated with 
increasing concentrations of GST-SNX9-SH3 (left) to a ﬁ  xed concentration of EspF peptide by ﬂ  uorescence polarization (see Materials and methods). 
(F) HEK293A cells were cotransfected with EGFP-EspF or triple mutant EGFP-EspF-D3 (top diagram) and V5-tagged SNX9. Anti-GFP immunoprecipitations (IP) 
were probed by V5 immunoblot (IB) (top panel). Cell lysates were probed by V5 or GFP immunoblot to show input levels (bottom two panels).JCB • VOLUME 178 • NUMBER 7 • 2007  1268
to two distinct regions within residues 75–81 and 122–128 
(Fig. 2 D). Remarkably, these regions in EspF both possess a com-
mon RxAPxxP motif that conforms to the SNX9 SH3 consensus-
binding motif identifi  ed in our unbiased phage display. Because 
residues 75–81 and 122–128 are found at the N-terminal por-
tion of PRR domain 1 and 2, respectively, and because homo-
logous regions are found in all EspF orthologues, we can conclude 
that each PRR domain of EspF possesses a single SNX9 bind-
ing site (see the alignment in Fig. 1). In support of this con-
clusion, a dissociation constant of 2.2 μM was experimentally 
derived from an EspF peptide (RPAPPPP) bound to the SNX9-
SH3 domain (Fig. 2 E), suggesting that these residues constitute 
the minimal sequence required for SNX9 interaction. In addi-
tion, we substituted aspartic acids for the arginines in position 
75, 122, and 169 (Arg
75,122,169→Asp or EspF-D3) in all three 
PRR domains of EPEC EspF. Mutant EspF-D3 failed to bind 
SNX9 in both in vitro pull-down assays (unpublished data) and 
coimmunoprecipitation experiments (Fig. 2 F).
EspF induces Arp2/3-dependent actin 
assembly through the direct activation 
of N-WASP
Next, we turned to the interaction between EspF and N-WASP. 
Full-length N-WASP interacted with EspF in coimmunoprecip-
itation assays, but not with control EGFP (Fig. 3 A). This inter-
action was comparable to the interaction between N-WASP and 
prophage-expressed EspFU/TccP gene that displays 35% iden-
tity to EspF (Fig. 1 B) (Garmendia et al., 2006). These data sug-
gest that the functionally distinct EspF and EspFU/TccP proteins 
both interact with N-WASP in eukaryotic cells.
We tested the ability of EspF to directly activate N-WASP 
by assaying Arp2/3 complex-dependent actin polymerization 
  kinetics using a pyrene-actin assembly assay in vitro. For these 
assays, we used Arp2/3-complex purifi  ed from bovine brain 
  extracts and purifi  ed N-WASP ∆EVH1 (residues 138–501), an 
N-WASP truncation mutant lacking the WH1/EVH1 domain 
that exhibits strong autoinhibition (Fig. 3 B) (Co et al., 2007). 
In  addition, a purifi  ed 6×-His tagged EspF protein possessing three 
intact PRR domains was used in these studies (EspF∆47, resi-
dues 48–206) (Fig. 3 B). In the absence of either N-WASP or the 
Arp2/3 complex, EspF did not alter F-actin assembly dynamics 
(Fig. 3 C). However, in the presence of both Arp2/3 and N-WASP 
∆EVH1, EspF stimulated actin nucleation (Fig. 3 C). These data 
indicate that EspF directly activates N-WASP in vitro.
As demonstrated in Fig. 1 D, residues 200–258 encom-
passing the Cdc42 binding CRIB domain of N-WASP consti-
tuted the minimal interaction site with EspF, suggesting that 
EspF could functionally mimic this GTPase. We used an engi-
neered “mini N-WASP” protein possessing the minimal Basic and 
CRIB regulatory domains linked to the Arp2/3 activating VCA 
domain to test this hypothesis (Fig. 3 B) (Prehoda et al., 2000). 
EspF potently stimulated mini-N-WASP in a dose-dependent 
manner and the half-maximal activity of mini-N-WASP occurred 
at an EspF concentration of 11.8 nM as determined by satura-
tion binding experiments (Fig. 3 C). In total, these data indicate 
that EspF can relieve N-WASP autoinhibition through a direct 
binding interaction with the CRIB regulatory domain.
EspF nucleates an active complex 
composed of SNX9 and N-WASP in vitro
Because both N-WASP and SNX9 bind to residues within the 
PRR domains of EspF, it was important to determine if their 
binding sites were mutually exclusive. We found that the SNX9 
binding defi  cient mutant EspF-D3 induced mini-N-WASP–
dependent actin polymerization to a similar extent as EspF, sug-
gesting that the RxAPxxP motif did not play a role in N-WASP 
activation (Fig. 3 E). Moreover, addition of saturating concen-
trations of GST-SNX9-SH3 (10 μM) to EspF had a minor affect 
on N-WASP activation (Fig. 3 E), suggesting the possibility that 
EspF can bind SNX9 and N-WASP through two distinct inter-
action sites.
To directly test the ability of EspF to nucleate a functional 
SNX9 and N-WASP complex, we fi  rst incubated recombinant 
EspF with GST-SNX9-SH3 immobilized to glutathione-Sepharose 
beads (Fig. 3 F). The formation of a stable protein complex be-
tween the SH3 domain (34 kD) and EspF (26 kD) was con-
fi  rmed by SDS-PAGE analysis (Fig. 3 F). Next, we added the 
stable SH3/EspF complex to mini-N-WASP and measured actin 
polymerization rates (Fig. 3 G). The SH3/EspF complex directly 
activated mini-N-WASP–mediated actin assembly kinetics (Fig. 
3 G, blue). In control experiments, actin polymerization kinet-
ics were not increased with SH3 beads alone (Fig. 3 G, gray), 
with mutant EspF-D3 that could not form a complex with the 
SH3 beads (Fig. 3 G, purple), or with GST control proteins (Fig. 
3 G, black). In total, these data provide strong evidence that 
EspF coordinates the binding of SNX9 and the activation of 
N-WASP through two independent binding motifs found within 
its highly conserved PRR domains (see Fig. 1 B).
EspF dynamics observed in living cells
SNX9 and N-WASP participate in several membrane traffi  cking 
events and localize to cellular membranes at CCPs and traffi  ck-
ing organelles (Merrifi  eld et al., 2002, 2005; Benesch et al., 
2005; Soulet et al., 2005; Yarar et al., 2005). We used total inter-
nal refl  ection-fl  uorescence microscopy (TIR-FM), a technique 
that allows fl  uorophore-conjugated proteins to be visualized 
within 100 nm of the cell surface (Steyer and Almers, 2001), 
to determine if EspF also localized to the plasma membrane in 
living cells. EGFP-EspF was transfected into Swiss-3T3 cells 
stably expressing DsRed-Clathrin light chain- a (Clc-DsRed), 
a cellular marker of CCPs and the plasma membrane (Merrifi  eld 
et al., 2002). Several 10–12-min videos were recorded in which 
EGFP-EspF and Clc-DsRed fl  uorescence was simultaneously cap-
tured by dual-color TIR-FM (Video 1, available at http://www
.jcb.org/cgi/content/full/jcb.200705021/DC1).
Analysis of living cells indicated that EspF was highly dy-
namic at the plasma membrane and it transiently accumulated into 
patches at the cell surface (Video 1). Interestingly, EspF partially 
colocalized with clathrin in still images (Fig. 4 A) and examination 
of time-resolved videos indicated that 92% (357 of 388 events 
from 8 cells) of clathrin structures transiently colocalized with 
EspF (Fig. 4 B and Video 2, available at http://www.jcb.org/cgi/
content/full/jcb.200705021/DC1). In addition, larger EspF tu-
bules could be found extending near the cell surface (Video 3). 
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lifetime of clathrin at the plasma membrane was nearly identical 
between untransfected cells (62 ± 4 s, n = 60 events) and EGFP-
EspF transfected cells (64 ± 5 s, n = 58 events) (Fig. 4 C). These 
dynamics were similar to those previously reported for clathrin in 
Swiss 3T3 cells (Merrifi  eld et al., 2002).
We noticed that the spatial and temporal dynamics of 
EspF were exquisitely coordinated with clathrin-mediated endo-
cytic events. To quantify these observations, the surface ki-
netics of EspF was directly compared with clathrin dynamics. 
As a reference index, the Clc-DsRed fl  uorescence intensity values 
of 25 clathrin structures were measured from 8 cells expressing 
EGFP-EspF. We analyzed events in which clathrin appeared at 
the plasma membrane, was stable for  60 s in the TIR-FM 
imaging field, and exponentially decayed from the plasma 
membrane (Fig. 4 D, red trace). These measurements were di-
rectly compared with the EGFP-EspF fl  uorescence intensities at 
each CCP. By aligning all 25 EspF traces relative to clathrin 
membrane departure, it was clear that EspF displayed a tightly 
Figure 3.  EspF directly binds to and activates N-WASP. (A) HEK293A cells were cotransfected with EGFP-EspF, EGFP-EspFu/TccP, or control EGFP and 
V5-tagged N-WASP. Anti-GFP immunoprecipitations (IP) were probed by V5 immunoblot (IB) (top). Cell lysates were probed by V5 or GFP immunoblot to show 
input levels (bottom two panels). (B) A diagram depicting N-WASP ∆EVH1 and mini-N-WASP proteins used in actin polymerization experiments and a 
Coomassie-stained gel of puriﬁ  ed 6×His EspF∆47 (residues 48–206) used in the actin polymerization experiments. (C) Pyrene-actin assembly assay demon-
strating EspF activates N-WASP in vitro. The polymerization kinetics of actin alone (red) was not increased by addition of 500 nM EspF (gold). Polymerization 
curves of Arp2/3 and N-WASP∆EVH1 (light green) compared with these components plus 500 nM EspF (blue) is shown. Unless otherwise stated, all assays 
contain 2.5 μM pyrene-actin, 40 nM Arp2/3 complex, and 100 nM N-WASP proteins. (D) EspF activates mini-N-WASP in vitro. A pyrene-actin assembly 
assay showing that EspF activated mini-N-WASP in a dose-dependent manner (blue). The rate of actin polymerization for each EspF concentration was deter-
mined at 2 μM G-actin consumption (80%) and plotted against EspF protein concentration (right graph). (E) Pyrene actin assembly assays comparing EspF 
(100 nM) and mutant EspF-D3 (100 nM) activating mini-N-WASP. Addition of 10 μM GST-SNX9 (SH3) domain to EspF∆47 had a negligible affect on mini-
N-WASP activation. (F) Schematic depicting the experimental procedure for Fig. 3 G (left) and an SDS-PAGE of GST (1), GST-SNX9-SH3 (2), GST-SNX9-SH3 
in complex with EspF∆47 (3), and GST-SNX9-SH3 control that did not form a complex with mutant EspF-D3 (4). The mobility of the stable SH3/EspF∆47 
complex is indicated. Non-speciﬁ  c (NS) bands are indicated (*). (G) Mini-N-WASP actin polymerization assay on protein complexes described in Fig. 3 F.JCB • VOLUME 178 • NUMBER 7 • 2007  1270
coordinated spatiotemporal localization pattern at the plasma 
membrane. First, EspF was recruited to the plasma membrane 
at preexisting CCPs (Fig. 4 D, green trace). The peak EspF 
fl  uorescence signal coincided with the exponential decay of 
clathrin signal from the plasma membrane (Fig. 4 D, arrow). 
Because these clathrin dynamics are indicative of clathrin coated-
vesicle movement away from the plasma membrane and vesicle 
scission (Merrifi  eld et al., 2005), EspF is likely to associate with 
actively budding membrane domains. Second, EspF remained 
at the cell surface beyond the time of clathrin departure, sug-
gesting that EspF was associated with the plasma membrane 
and not in CCPs (Fig. 4 D). Finally, EspF signal decayed in the 
TIR-FM image, indicating its retreat from the plasma membrane.
Next, we examined if EspF dynamics at the plasma 
membrane correlated with the protein interactions defi  ned by 
our in vitro data. The triple-mutant EspF-D3 protein did not 
interact with SNX9, but maintained N-WASP binding activity 
(Fig. 2 F and Fig. 3 E). Therefore, this mutant was used to de-
termine the potential contributions of SNX9 binding on EspF 
dynamics. We recorded several TIR-FM videos from cells 
expressing EGFP-EspF-D3 (Fig. 4 E) and compared its dynam-
ics to wild-type EspF (Fig. 4 F). EspF-D3 was recruited to 86% 
(112 of 130 events from 5 cells) of cell surface clathrin struc-
tures. Unlike EspF, however, EspF-D3 departed from the plasma 
membrane coincident with or slightly before clathrin-mediated 
endocytosis (Fig. 4 F). The average lifetime of EspF-D3 asso-
ciated with endocytic sites (12.3 ± 5 s, n = 108 events) was 
approximately fi  vefold shorter than wild-type EspF (68 ± 14.5 s, 
n = 98 events) (Fig. 4 G). It was also clear that EspF-D3 did 
not exhibit the prolonged plasma membrane localization that 
wild-type EspF displayed after clathrin departure. These data 
are consistent with the ability of EspF to interact with SNX9 
at the plasma membrane (Fig. 4 H); however, additional experi-
mental approaches are necessary to directly establish this link.
Figure 4.  EspF transiently associates with clathrin at endocytic sites. (A) Dual-color TIR-FM image of cells expressing EGFP-EspF and Clc-DsRed and merged 
image showing partial colocalization. (B) Time series of two stereotypical EspF puncta correlated with simultaneous Clc-DsRed dynamics using live cell 
TIR-FM. Arrows track a single clathrin endocytic event. (C) The cell surface lifetimes of Clc-DsRed in untransfected, EGFP-EspF, and EGFP-EspF-D3 transfected 
Swiss-3T3 cells. The average lifetime and SEM of CCPs from at least ﬁ  ve cells are shown. (D) Average ﬂ  uorescence traces of Clc-DsRed (red) or EGFP-EspF 
(green) from 25 individual CCPs. Arrow indicates the time of peak EGFP-EspF signal at the moment of clathrin departure. SEM of averaged traces is shown. 
Time points represent (1) the recruitment of EspF, (2) the assembly phase of EspF at the plasma membrane, and (3) the departure of EspF. (E and F) Analysis 
of individual EGFP-EspF (E) or EGFP-EspF-D3 (F) puncta by TIR-FM. Top: kymograph representation of single CCPs. Bottom: representative ﬂ  uorescence trace 
of single CCPs as described in D. (G) The cell surface lifetimes of EGFP-EspF or mutant EspF-D3 associated with endocytic sites are shown. The average life-
time and SEM of  100 CCPs events from at least ﬁ  ve cells and three separate experiments are shown. (H) Diagram depicting EspF associated with highly 
curved membranes at single CCPs.ESPF NUCLEATES A MEMBRANE-TRAFFICKING SIGNALING COMPLEX • ALTO ET AL. 1271
EspF remodels cellular membranes through 
the activation of SNX9
Using wide-fi  eld fl  uorescence microscopy, we found that en-
dogenous SNX9 localized to CCPs at the surface of HeLa cells 
and accumulated in perinuclear regions near the Golgi appa-
ratus (Fig. 5 A) (Lundmark and Carlsson, 2003; Soulet et al., 
2005). Transient transfection of EspF induced a redistribution of 
SNX9 from CCPs and perinuclear regions to “worm-like” tubular 
structures found near the cell periphery (Fig. 5 A; Fig. S1 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705021/DC1). 
In these cells SNX9 and EspF colocalized at tubular structures, 
suggesting that SNX9 redistribution was directly associated 
with EspF binding (Fig. 5 A and Fig. S1 B). Consistent with this 
notion, mutant EspF-D3 had no affect on SNX9 localization. 
To test these observations in a more controlled cellular environ-
ment, we artifi  cially increased the SNX9 expression levels by 
transfecting mCherry-SNX9 into HeLa cells. Exogenous SNX9 
had a predominantly perinuclear localization and a small pro-
portion could also be found in cell surface puncta reminiscent 
of CCPs (Fig. 5 B). We found that coexpression of EspF with 
SNX9 induced an array of tubular structures that extended into 
dense tubular networks (Fig. 5 B). Similar tubular networks 
were identifi  ed in >90% of EspF and SNX9 cotransfected cells 
and both proteins colocalized at these sites (Fig. 5, B and C). 
As expected, mutant EspF-D3 failed to induce SNX9 tubules 
indicating that SH3 binding is required for SNX9 localization. 
Moreover, wild-type EspF did not induce tubules upon cotrans-
fection of SNX9∆BAR, a C-terminal deletion mutant of SNX9 
in which the putative membrane deforming BAR domain was 
removed (Fig. 5, B and C). These data reveal a novel activity 
of SNX9 to induce cellular tubulation, a phenomenon that is 
directly linked to EspF binding.
To determine the nature of the abnormal tubules formed 
by coexpression of EspF and SNX9, EspF was fi  rst immuno-
  localized by electron microscopy (EM). EspF decorated tubular 
and vesicular membrane structures but was not found in nuclear 
areas, inside organelles, or randomly distributed throughout the 
cytoplasm (Fig. 5 D). Using thin-section EM we identifi  ed a 
striking array of membrane structures in EspF transfected (Fig. 
5 E) but not untransfected cells (Fig. 5 F). The EspF-induced 
tubules were abnormally curved and in many cases budding 
profi  les could be observed along both sides of the membrane 
tubules (Fig. 5 G). In addition, unusually long ( 0.5 μm) cell 
surface invaginations appeared to be continuous with the plasma 
membrane (Fig. 5 H) and several membrane projections exten-
ded from multivesicular organelles (Fig. 5 I). A dense negative 
stain was also observed around the new membrane structures, 
most likely representing the EspF/SNX9 protein coat. We now 
propose a model whereby EspF activates SNX9; engagement 
of the SNX9-SH3 domain by the highly specifi  c EspF-ligand 
motif exposes the C-terminal BAR domain to induce membrane 
remodeling in eukaryotic cells.
EspF coordinates membrane remodeling 
and actin polymerization in cells
N-WASP was originally shown to induce cell surface fi  lopodia 
projections during cell migration (Miki et al., 1998); however, 
recent fi  ndings indicate that it also regulates membrane traffi  ck-
ing events including actin-based vesicular transport and endo-
cytosis (Merrifi  eld et al., 2002, 2004; Benesch et al., 2005; 
Innocenti et al., 2005; Yarar et al., 2005). We did not detect the 
formation of cell surface fi  lopodia in EspF-transfected cells. 
However, de novo F-actin nucleation occurred near membrane 
tubules induced by EspF and SNX9 coexpression (Fig. 6 A; 
Fig. S2 A, available at http://www.jcb.org/cgi/content/full/jcb
.200705021/DC1). EspF activation of SNX9 was prerequisite 
for these downstream signaling events, as F-actin appeared nor-
mal in cells expressing mutant EspF-D3 (Fig. 6 B). These data 
suggest that membrane tubulation occurs before actin poly-
merization in the EspF/SNX9/N-WASP signaling cascade. In 
support of this conclusion, depolymerization of actin had no 
affect on the formation of membrane tubules; however F-actin 
was perturbed at these sites (Fig. S2, C and D). Moreover, N-WASP 
redistributed from the cellular cytoplasm to membrane tubules 
in EspF-transfected cells (Fig. 6 C) but not in cells expressing 
mutant EspF-D3 (Fig. 6 D). In total, these data indicate that 
membrane targeting and subsequent remodeling by EspF is re-
quired for its activation of downstream signaling events.
Several additional lines of evidence also suggest that EspF 
activates N-WASP at membrane sites. Careful examination of 
the cell surface dynamics of EspF by TIR-FM indicated that a 
small proportion of EspF puncta ( 5%) formed “comet tails” 
and seemed to propel the clathrin structure over a very short dis-
tance just before clathrin internalization (Fig. 6 E; Video 4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200705021/DC1). 
This EspF behavior is reminiscent of actin fi  lament dynamics 
observed in Listeria comet tails (Theriot et al., 1992) and the 
projectile motion of endocytic vesicles at the tips of actin tails 
(Merrifi  eld et al., 1999). EspF was also found at mobile clathrin 
structures that moved parallel to the plasma membrane, a pheno-
type that may occur due to changes in the actin cytoskeletal 
architecture (Fig. 6 F; Video 5) (Yarar et al., 2005). In total, 
these cellular observations indicate that EspF functions as a 
bacterial signaling node, integrating the activation of two sig-
naling cascades at membranes of eukaryotic cells (Fig. 6 G).
Investigation of bacterial delivered EspF 
in polarized epithelial cells
Next, we sought to determine the potential role of EspF signal-
ing in epithelial models of EPEC infection. Genetic studies 
have implicated EspF in several pathogenic phenotypes, includ-
ing the deregulation of the tight-junction ion barrier function 
in EPEC-infected polarized epithelial cells (McNamara et al., 
2001; Dean and Kenny, 2004; Shiffl  ett et al., 2005). We found 
a dramatic loss of trans-epithelial electrical resistance (TER, 
a measure of tight junction integrity) in polarized T84 colonic ep-
ithelial cells infected with wild-type EPEC that was dependent 
on the espF gene (Fig. 7 A) (McNamara et al., 2001). Interest-
ingly, both plasmid-expressed EPEC espF (pespF) as well as 
EHEC espFu/tccp (pespFu/tccp) trans-complemented the espF
− 
mutant strain (Fig. 7 A) (Viswanathan et al., 2004). Similarly, we 
found that espF
− mutant strain expressing the SNX9 binding–
defi  cient mutant EspF-D3 (pespF-D3) also induced a loss of 
TER (Fig. 7 A). These confounding data suggest that multiple JCB • VOLUME 178 • NUMBER 7 • 2007  1272
genes in EPEC are responsible for tight junction breakdown and 
suggest that the complex phenotype cannot be ascribed to EspF 
function alone.
Next, we wanted to directly test the cytoplasmic role of 
EspF in polarized epithelial cells. Tight junction breakdown 
was monitored by the redistribution of occludin from a uniform 
band outlining the cell junctions in uninfected cells (Fig. 7 B) 
to a discontinuous beaded pattern in EPEC infected cells 
(Fig. 7 C). To directly test the role of EspF in this process, stable 
cell lines expressing a tandem affi  nity protein tag (TAP; protein A 
and fl  ag) fused to the N-terminus of EPEC EspF were created 
(Fig. 7 D). As shown in Fig. 7 E, TAP-EspF was expressed in 
Figure 5.  EspF activates SNX9 to form membrane tubules in vivo. (A) Fluorescence microscopy of endogenous SNX9 from EGFP, EGFP-EspF, or EGFP-EspF-
D3 transfected HeLa cells. Inset shows the accumulation of SNX9 at CCPs or new tubule structures. Bar = 15 μm. (B) Fluorescence microscopy of HeLa cells 
transfected with mCherry-SNX9 or the EGFP constructs and mCherry-SNX9 as indicated. Inset shows CCPs (arrows) or new tubule structures. Bar = 15 μm. 
(C) Quantiﬁ  cation of tubule networks in HeLa cells cotransfected with the indicated plasmids. Graphs represent the percentage of transfected cells with tu-
bule networks from at least three independent experiments and SEM is shown. Wild-type (Wt), mutant EspF-D3 (D3), and SNX9∆BAR (∆BAR) are indicated. 
(D) Immunoelectron micrograph of EGFP-EspF in HeLa cells cotransfected with mCherry-SNX9. Sections were labeled with anti-GFP polyclonal antibody and 
10 nm protein A-gold. Bars for large image (250 nm) and magniﬁ  cation (50 nm) are indicated. (E–I) Thin-section electron micrograph of EspF- and SNX9-
transfected HeLa cells containing multiple membrane tubules showing irregular shapes (arrows) (E). Untransfected controls (F) and representative examples 
of unusual membrane tubules in EspF transfected cells are shown (G–I). Bars: 500 nm (E and F), 200 nm (G–I).ESPF NUCLEATES A MEMBRANE-TRAFFICKING SIGNALING COMPLEX • ALTO ET AL. 1273
every cell and localized to small puncta near the apical cell   surface. 
SNX9 interaction seemed to be required for this localization as 
the SH3-binding mutant EspF-D3 was distributed throughout 
the cytoplasm and accumulated in nuclear regions (Fig. 7 F). 
Importantly, MDCK cells expressing either EspF or EspF-D3 
formed normal tight junctions (Fig. 7, E and F), suggesting that 
EspF activity alone is not suffi  cient to break down tight junc-
tions. Next, we biochemically purifi  ed EspF from MDCK cells 
as an unbiased approach to determine protein complexes asso-
ciated with EspF in a polarized cell type (Fig. 7 G). TAP-purifi  ed 
EspF or control parental cell lines were separated by SDS-PAGE 
and Coomassie stain indicated that the major EspF-binding pro-
tein had a molecular weight of  70 kD (Fig. 7 G). This protein 
was unambiguously identifi  ed as canine SNX9 (MW = 71 kD) 
by tandem mass spectrometry from two independent experiments 
(see Materials and methods). Thus, SNX9 is the major target of 
cytoplasmic EspF in polarized epithelial cells.
Finally, we sought to determine if the localization and 
function of bacterial delivered EspF relies on interaction with 
SNX9 in polarized cell types. Human CaCo2 intestinal epithelial 
cells were infected with wild-type EPEC or the espF
− mutant 
strain. Whereas wild-type EPEC induced SNX9 membrane tu-
bules, this phenotype did not occur in espF
− mutant EPEC-
  infected cells (Fig. 7 H). The wild-type phenotype was rescued 
by introducing a plasmid encoding the espF allele (pespF ) into 
the mutant espF
− strain (Fig. 7 H). However, there was no pheno-
type associated with mutant strains complemented with SNX9 
binding–defi  cient espF-D3 (pespF-D3) (Fig. 7 H). Similar results 
were also found in EPEC-infected HeLa cells (unpublished data). 
Western blot analysis confi  rmed the expression and secretion of 
the EspF proteins by wild-type and trans-complemented strains 
(Fig. 7 I). These data further indicate that the biochemical activ-
ities of EspF that we have described in vitro are likely to occur 
during EPEC pathogenesis of intestinal epithelial cells.
Discussion
In this study we have obtained evidence for a new model of 
EspF function during bacterial pathogenesis. Our data suggest 
that EspF physically links membrane-traffi  cking proteins to the 
actin polymerization machinery in host cells. Several lines of evi-
dence support this hypothesis. First, EspF interacts directly with 
SNX9 through a highly evolved SH3 domain–binding motif that 
is repeated several times throughout the EspF coding sequence. 
Second, EspF stimulates N-WASP/Arp2/3 actin polymerization 
in reconstitution experiments. Third, our live-cell imaging studies 
revealed that EspF dynamically localized to CCPs. This subcellu-
lar localization is similar to those previously described for both 
SNX9 and N-WASP (Merrifi  eld et al., 2004; Benesch et al., 2005; 
Innocenti et al., 2005; Soulet et al., 2005). Fourth, EspF induced 
membrane remodeling through the activation of SNX9, and the 
actin polymerization profi  les at these sites correlated with the 
ability of EspF to interact with N-WASP in cells. Finally, the EspF-
dependent redistribution of SNX9 during bacterial infection sug-
gests that the biochemical and cellular activities that we have 
described are likely to occur during natural EPEC pathogenesis.
Figure 6.  EspF induces N-WASP activation at membrane tubules. (A and B) Fluorescence microscopy images depicting mCherry-SNX9 and FITC-phalloidin 
(actin) in EspF (A) or EspF-D3 (B) transfected HeLa cells. Bar = 15 μm. (C and D) Fluorescence microscopy images of HeLa cells cotransfected with EGFP-
EspF (C) or EGFP-EspF-D3 (D) with mCherry-SNX9 and N-WASP-V5. N-WASP was detected by anti-V5 immunocytochemistry. Bar = 15 μm. (E) Time series of 
EspF puncta (EGFP-EspF) exhibiting a “rocketing” phenotype (arrow) from live cell TIR-FM. Cartoon below. (F) Time series of EspF puncta (EGFP-EspF) exhibit-
ing a mobile phenotype from live cell TIR-FM. Images are correlated with simultaneous Clc-DsRed dynamics showing the movement of a single CCP (arrow). 
(G) Schematic of EspF functioning as a node of signaling integration at eukaryotic membranes.JCB • VOLUME 178 • NUMBER 7 • 2007  1274
Activation of SNX9 and N-WASP 
by EspF: a potential mechanism 
for signal ampliﬁ  cation and speciﬁ  city 
in eukaryotic cells
The major functional unit of EspF is composed of 3–5 highly 
conserved proline-rich repeat (PRR) domains of  47 amino   acids. 
The purpose of the repeat sequences and how they confer a eu-
karyotic signaling response is largely unknown. Recently, EspF 
was shown to bind SNX9 through an SH3 domain interaction; 
however, the molecular details and the signifi  cance of this 
 fi nding were left unexplored (Marches et al., 2006). We have 
expanded these initial observations by considering both the 
 biochemical  specifi  city of this protein–protein interaction and 
applying this knowledge to cellular models of EspF function. 
EspF possesses a single RxAPxxP motif at the N-terminal por-
tion of each PRR domain that confers binding selectivity to the 
SH3 domain of SNX9. This confi  guration allows between three 
and fi  ve high affi  nity SNX9 bindings sites per EspF molecule. 
Figure 7.  SNX9 is the major binding partner for EspF in polarized epithelial cells. (A) TER measurements of polarized T84 colonic epithelial cells infected 
with EPEC and the indicated EspF mutants. The average change in TER in three independent experiments is shown. (B and C) Fluorescence microscopy of 
MDCK cells uninfected (B) or infected with EPEC for 4 h (C). Tight junction morphology was detected by anti-occludin immunocytochemistry. (D) Schematic 
of TAP tagged EspF is shown. Western blot of cellular lysates collected from stable MDCK cells expressing TAP-ﬂ  ag-EspF or mutant TAP-ﬂ  ag-EspF-D3. Anti-
ﬂ  ag was used to probe EspF expression (top blot) and actin was used as a protein loading control (bottom blot). (E and F) Fluorescence microscopy of 
MDCK cells expressing TAP-EspF and TAP-EspF-D3. Tight junction morphology was detected by anti-occludin immunocytochemistry. (G) MDCK parental or 
Tap-EspF cellular lysates were incubated with anti-ﬂ  ag agarose and the resulting immuno-complexes were subjected to SDS-PAGE and stained with Coomassie. 
Proteins identiﬁ  ed by mass spectrometry are indicated. “NS” designates nonspeciﬁ  c interacting proteins and “IgG LC” is the immunoglobulin light chain. 
(H) Anti-SNX9 immunoﬂ  uorescence microscopy of CaCo2 cells infected with the indicated EPEC strains for 3 h. Boxed area is a 4× magniﬁ  cation of the 
area indicated. Cellular borders are outlined. Bar = 15 μm. (I) Immunoblot of EspF from wild-type EPEC (Wt) or EPEC espF
− strains carrying plasmids encod-
ing wild-type EspF (pespf) or mutant EspF-D3 (pespf-D3) tagged with the myc epitope. Type III secreted EspF harvested from media supernatants (top) and 
from whole bacterial lysates (bottom) are shown. Concentrations of IPTG are indicated below.ESPF NUCLEATES A MEMBRANE-TRAFFICKING SIGNALING COMPLEX • ALTO ET AL. 1275
Thus, the PRR domains may provide the bacterial effector a 
mechanism to increase protein avidity, or more interestingly, 
a means to amplify the SNX9 signal through oligomerization 
(Yarar et al., 2007). Consistent with these biochemical fi  ndings, 
engagement of the SNX9 SH3 domain by EspF induced robust 
membrane tubulation in cells. We now propose a concerted 
model for EspF function; direct binding to the SH3 domain of 
SNX9 transmits a membrane-remodeling signal to the C-terminal 
BAR domain. Importantly, similar membrane tubules have been 
observed upon expression of other BAR domain proteins (Peter 
et al., 2004), and we found that EspF-induced membrane tubu-
lation did not occur with a BAR domain deletion mutant of 
SNX9. The potential importance and mechanism of these intra-
molecular interactions will be clarifi  ed as the EspF/SNX9 effec-
tor system is analyzed in biophysical detail.
Although we have focused primarily on the mechanisms 
of SNX9 activation by EspF, we have also discovered that EspF 
regulates actin cytoskeletal dynamics. In the context of the 
pyrene-actin assembly assay, the PRR domains in EspF are suf-
fi  cient to induce N-WASP/Arp2/3 actin nucleation. EspF binds 
directly to the CRIB regulatory domain in N-WASP, a phenom-
enon similar to the reported mechanism of the Rho GTPase 
Cdc42. Similar fi  ndings have been previously reported for the 
functionally distinct PRR protein EspFu/TccP (Garmendia et al., 
2006), indicating that both EspF and EspFu/TccP may use 
  similar residues to independently activate N-WASP (Fig. 1). 
In addition, we have extended these fi  ndings by demonstrating 
that EspF nucleates a trimeric complex composed of SNX9 and 
N-WASP. This complex may provide EHEC 0157:H7 a potent 
mechanism for eukaryotic signal amplifi  cation and downstream 
signaling specifi  city during bacterial pathogenesis. For exam-
ple, bacterial pedestals could be modifi  ed by EspFu/TccP acti-
vation of N-WASP (Campellone et al., 2004) while membrane 
traffi  cking would be regulated by EspF and the SNX9/N-WASP 
complex. This idea is particularly intriguing in light of studies 
by Yarar et al. (2007) that demonstrate the importance of SNX9 
oligomerization to activate N-WASP during multiple modes of 
eukaryotic endocytosis.
EspF mimics an endogenous actin/
membrane-signaling module to regulate 
membrane trafﬁ  cking events
Genetic studies have linked EspF activity to a wide range of 
  biological activities, including mitochondrial apoptosis (Crane 
et al., 2001; Nougayrede and Donnenberg, 2004), epithelial 
barrier disruption (McNamara et al., 2001), apical microvilli 
effacement (Dean et al., 2006), and inhibition of macrophage 
phagocytosis (Quitard et al., 2006). We found EspF to be neces-
sary but not suffi  cient to regulate epithelial tight junction archi-
tecture during bacterial pathogenesis (see Fig. 7), suggesting 
that the EspF phenotypes observed in bacterial genetic studies 
may result from the concerted actions of several type III effector 
proteins or additional bacterial signaling mechanisms (Dean 
et al., 2006). Taking an alternative approach to bacterial genetics, 
we found that purifi  ed EspF binds directly to SNX9 in vitro and 
activates N-WASP in reconstitution assays. These activities 
could have direct and profound effects on membrane traffi  cking 
and the overall homeostasis of infected intestinal epithelial 
cells. For example, a recent report suggests that the Aquaporin 
(AQP) water channels are mislocalized during A/E pathogen 
  infection, and this phenotype requires EspF expression (Guttman 
et al., 2007). In addition, EspF promotes the internalization of 
tight junction proteins in vivo (Guttman et al., 2006), poten-
tially through a membrane-traffi  cking phenotype. These possi-
bilities are consistent with our observed localization of EspF 
at clathrin structures, as membrane traffi  cking is required for 
epithelial tight junction maintenance and the formation of the 
apical/basolateral poles (Wells et al., 2006).
It is intriguing to note that the coordinated activation of 
SNX9 and N-WASP by EspF may actually represent a patho-
genic strategy to mimic a natural host SNX9/N-WASP signaling 
complex. In earlier studies, our lab found that the Drosophila 
SNX9 (DSH3PX1) links axonal guidance receptors directly to 
N-WASP and the actin cytoskeleton (Worby et al., 2001). In ad-
dition, more recent studies suggest that engagement of the T cell 
antigen receptor (TCR) combined with costimulation of CD28 
evoked the formation of a SNX9/WASP complex at endocytic 
sites of T cells (Badour et al., 2007). Together, these data es-
tablish the importance of an endogenous SNX9 and N-WASP 
signaling complex to regulate diverse eukaryotic traffi  cking 
events. Importantly, the functional link between these proteins 
may extend beyond clathrin-mediated endocytosis. Yarar et al. 
(2007) have described a mechanism in which SNX9 directly ac-
tivates N-WASP for the purpose of regulating dorsal membrane 
ruffl  es, clathrin-independent fl  uid-phase endocytosis, and uptake 
of GPI-anchored proteins. Thus, our data suggest for the fi  rst 
time that EspF hijacks an endogenous SNX9/N-WASP signaling 
complex involved in multiple host cellular regulatory pathways.
Materials and methods
Plasmids
The espf gene from EHEC O157:H7 (GenBank accession no.#AP002566) 
and the EPEC E2348/69 espf were PCR cloned in-frame into pEGFP-C2 
(CLONTECH Laboratories, Inc.). The espfu/tccp gene was cloned from 
a clinical isolate of EHEC 0157:H7 and has the sequence identical to 
GI: 15831969. The yeast two-hybrid clone of mouse SNX9 (NM_025664) 
residues 1–111, as well as full-length human SNX9, N-WASP, Grb2, NckI, 
and Nck2 were Topo cloned into pcDNA3.1-V5-His (Invitrogen). To produce 
mCherry-SNX9, the EGFP from pEGFP-C1 was replaced with mCherry by 
PCR subcloning. For bacterial expression, 47 amino acid N-terminal dele-
tions (∆N47) of EspF were PCR subcloned into pGEX-4T1 (GST-tag) (GE 
Healthcare) or pet30A (6xHis tag) (Novagen). EspF-D3 was generated with 
Multi-site QuikChange Site-Directed Mutagenesis (Stratagene) following the 
manufacturer’s instructions. For bacterial complementation, the EPEC espf 
or mutant espf-D3 was Topo cloned into pTrcHis2 with a c-myc epitope 
tag (Invitrogen). GST and His-tagged mini-N-WASP were obtained from 
Wendall Lim (University of California, San Francisco, San Francisco, CA; 
Prehoda et al., 2000). All constructs were veriﬁ  ed by DNA sequencing.
Yeast two-hybrid
The yeast expression vector pLexA encoded a gene with N-terminal LexA 
binding domain and residues 1–248 of EHEC EspF. 250 μg of a d 9.5 
and 10.5 mouse embryo library in VP16 were screened using the yeast 
two-hybrid system as previously described (Alto et al., 2006).
Cell culture, transfection, and wide-ﬁ  eld ﬂ  uorescence microscopy
Cell culture, transfections, and wide-ﬁ  eld ﬂ  uorescence microscopy was per-
formed as previously described (Alto et al., 2006). Images were acquired on 
a microscope (Axiovert; Carl Zeiss Microimaging, Inc.) using a digital camera 
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(Universal Imaging, Corp.). Optical ﬁ   lters were obtained from Chroma 
Technologies and 40 or 63× objectives were used for image acquisition.
Antibodies
Concentrations of anti-GFP polyclonal and monoclonal (CLONTECH 
  Laboratories, Inc.), anti-His (QIAGEN), anti-GST, anti-ﬂ  ag M2, anti-ﬂ  ag 
polyclonal (Sigma-Aldrich), anti-HA (Covance), and anti-occludin (Zymed 
Laboratories) were used for immunoprecipitation, immunocytochemistry, 
and immunoblotting as recommended by the manufacturer. Rabbit poly-
clonal SNX9 antibody was used at 1:200 (Soulet et al., 2005). Rabbit 
polyclonal EspF was used at 1:10,000 (McNamara et al., 2001). Anti-
tubulin antibody was used at 1:200 (Sigma-Aldrich), and Latrunculin-A 
at 1 μM (Calbiochem).
Recombinant protein production and GST pull-down assays
Recombinant 6×His EspF∆47, mini-N-WASP (from Wendall Lim), N-WASP 
∆EVH1 (from Jack Taunton; University of California, San Francisco, San 
Francisco, CA) and SNX9 were produced in BL-21/DE3 E. coli strain fol-
lowing standard methods. Cells were lysed in either His buffer (50 mM Tris, 
pH 7.4, 300 mM NaCl, 10 mM imidazole, and 0.5% Triton-X 100) or 
GST buffer (phosphate-buffered saline) supplemented with protease cock-
tail (Roche). Proteins were puriﬁ   ed with Nickel agarose (QIAGEN) 
or glutathione-Sepharose (GE Healthcare) following the manufacturer’s 
instructions. Proteins were dialyzed overnight in 2 l of lysis buffer at 4°C. 
Glycerol was added to 30% and aliquots were stored at −80°C. For GST 
pull-down assays, 10 μg of recombinant GST proteins immobilized to 
glutathione-Sepharose was incubated with 50 μl of [
35S]-methionine 
(GE Healthcare) produced with TNT reaction (Promega) for 4 h at 4°C. Proteins 
were separated by SDS-PAGE, dried, and exposed by autoradiography.
Peptide array and SNX9 overlay
Immobilized peptides were synthesized on cellulose paper using a Multi-
pep Autospot synthesis robot following the manufacturer’s directions 
  (Intavis AG). Membranes were blocked in 5% milk in TBS-Tween. 50 μl 
of [
35S]-methionine SNX9 produced by TNT (Promega) was added to 5 ml 
of block solution and overlayed onto peptide membranes for 4 h at room 
temperature. Membranes were washed 3× 10 min in TBS-T and exposed 
by autoradiography.
Fluorescence polarization
FITC-labeled peptides (Cell Essentials) used for ﬂ  uorescence polarization 
include EspF residues 69–86 (FITC-A  T  S  F  T  P  S  R  P  A  P  P  P  T  S  G  Q  A  ) or control pep-
tide (FITC-Q  I  A  K  R  R  R  L  S  S  L  R  A  ). Peptides (5 nM) were suspended to working 
dilutions in PBS with 5 mg/ml BSA. Increasing concentrations of puriﬁ  ed 
GST-SNX9-SH3 or control GST proteins were mixed with peptides in 100 μl 
and incubated at room temperature for 10 min. Fluorescence polarization 
(FP) was measured on a GENios Pro (TECAN) ﬁ  tted with FP excitation and 
emission ﬁ  lters, 485/535 nm. Polarization values (mP) were determined at 
equilibrium and normalized to the highest value of saturation. Saturation 
binding curve was generated with PRISM software (Graph Pad) and disso-
ciation constants (KD) were calculated from the nonlinear regression curve 
from averages of three independent experiments.
Phage display
A library of random dodecapeptides fused to the N terminus of the M13 
gene-8 major coat protein was constructed and cycled through rounds of 
binding selections with the bacterially expressed SH3 domain immobilized 
on 96-well Maxisorp immunoplates (NUNC), as described previously 
(Sidhu et al., 2000; Laura et al., 2002). After four rounds of selection, 
individual phage were isolated and analyzed in a phage ELISA. Phage 
that bound to the SH3 domain was subjected to DNA sequence analysis.
Actin polymerization assays
1:1 mix of pyrene actin ( 40% labeled, ﬁ  nal is  20% labeled) to cold 
G-actin (Cytoskeleton, Inc.) were mixed in G-buffer (5 mM Tris, pH 8.0, 
0.2 mM CaCl2, 0.2 mM ATP, and 1 mM DTT) and centrifuged at 100,000 g 
for 2 h. A ﬁ  nal of 2.5 μM pyrene actin mix was added to 270 μl of Arp2/3 
buffer (20 mM Tris, pH 7.5, 25 mM KCl, 1 mM MgCl2, 0.1 mM ATP, and 
1 mM ATP). 40 nm bovine Arp2/3 (a gift from Tom Pollard; Yale University, 
New Haven, CT) and 100 nM mini-N-WASP or N-WASP ∆EVH1 was mixed 
with various concentrations of GST, GST-EspF, or SNX9 constructs in 30 μl of 
10× actin polymerization buffer (100 mM Tris, pH 7.5, 500 mM KCl, 20 mM 
MgCl2, and 10 mM ATP). 270 μl pyrene actin (2.5 μM) was mixed with 
30 μl mini-N-WASP-Arp2/3 and actin-assembly kinetics was monitored by 
pyrene ﬂ  uorescence over a 10–20-min time interval. Peak ﬂ  uorescence 
values were normalized to 2.4 μM actin consumption and graphed with 
PRISM Software.
Total internal reﬂ  ection ﬂ  uorescence microscopy (TIR-FM)
TIR-FM imaging procedures and microscopic manipulations were con-
ducted as previously reported (Yarar et al., 2005). Swiss 3T3 cells stably 
expressing clathrin-light chain DsRed (Merriﬁ  eld et al., 2002) were grown 
to 70% conﬂ  uency in a 100-mm tissue culture dish in DME + 10% fetal calf 
serum and transfected with 20 μg EGFP-EspF or EGFP-EspF-D3 DNA using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instruc-
tions. Cells were allowed to recover in fresh medium for 2 h, replated onto 
22 × 22-mm, no. 1.5 glass coverslips (Corning; n = 1.523), and ﬁ  lmed 
the following morning.
Total internal reﬂ  ection ﬂ  uorescence (TIRF) microscopy was performed 
using an inverted microscope (TE2000U; Nikon) custom-modiﬁ  ed to allow for 
through-the-objective multispectral total-internal reﬂ  ection ﬂ  uorescence micros-
copy using a 100×, 1.45 NA objective (Nikon), as previously described 
(Yarar et al., 2005). TIRF images were taken for 10 min at 2–3-s intervals, 
with a 100–300-ms exposure time, depending on the intensity of the signal.
Image analysis
Low expressing EGFP-EspF or EGFP-EspF-D3 cells stably expressing Clc-
DsRed were chosen for  8–12 min time-lapse movies. Stacks of red (Clc-
DsRed) and green (GFP-EspF) images were de-interleaved into separate 
stacks. Clc-DsRed stacks were analyzed for candidate clathrin structures 
that were stable for 30 s before disappearance and seemed likely to repre-
sent single CCPs. Clathrin structures were excluded similar to the criteria 
described previously (Merriﬁ  eld et al., 2002). We marked the position of 
each Clc-DsRed candidate with a  1–2-μm diameter circle and observed 
GFP-EspF dynamics at these sites. This procedure yielded the coordinates 
of the CCS in both the red and green channels so that red and green re-
gions precisely centered on the CCS could be excised and stored as minis-
tacks for analysis. All time and ﬂ  uorescence intensity measurements were 
based on these criteria. Image analysis was done with Metamorph (Universal 
Imaging Corp), Excel, and graphed using PRISM (Graph Pad).
To measure 25 CCPs, we ﬁ  rst chose 25 candidate CCPs from 8 dif-
ferent cells. Each CCP appeared during the 10-min video series was stable 
for at least 30 s, disappeared from the evanescent ﬁ  eld, and did not re-
appear for the remainder of the video series. The peak ﬂ  uorescence inten-
sity measurements were collected for each individual EspF and clathrin 
image and averaged background values were subtracted. Clathrin results 
were normalized to the mean ﬂ  uorescence during the 21 s (7 frames) before 
the peak clathrin ﬂ  uorescence (Merriﬁ  eld et al., 2002). The time of clathrin 
departure (time 0) was deﬁ  ned as the last frame in which the normalized 
ﬂ  uorescence value was within 90% of peak ﬂ  uorescence and the signal 
reached <5% over the following 45 s of imaging. Each clathrin event (n = 25) 
was aligned to the time of departure and averaged. For EspF, the results 
of each event were normalized to the mean of three contiguous intensity 
values, including the peak value, then aligned to the time of clathrin depar-
ture and ﬁ  nally averaged (Merriﬁ  eld et al., 2002). Kymograph analysis 
was performed using MetaMorph software.
EPEC infection experiments
T84 colonic epithelial cells were cultured and TER experiments were per-
formed as described previously (McNamara et al., 2001). EPEC and 
espF
− mutant strains (McNamara and Donnenberg, 1998) were comple-
mented with plasmid EspF subcloned into pTrcHis2 (Invitrogen). Plasmid 
EspF was expressed in EPEC by incubation with 100 μM IPTG for 3 h be-
fore EPEC infections. T84 cells were infected with an MOI of 100 for the 
indicated time points. CaCo2 experiments were performed by infecting 
cells with EPEC or the indicated mutants for 4 h before ﬁ  xation and immuno-
ﬂ  uorescence processing.
MDCK stable cell lines and mass spectrometry
TAP-tagged EspF or mutant EspF-D3 were subcloned into pCDNA4T/O 
and MDCK stable cell lines were generated following the manufacturer’s 
instructions (Invitrogen). Clonal lines expressing TAP-EspF or TAP-EspF-D3 
were selected with 500 μg/ml zeocin and conﬁ  rmed by Western blot and 
immunoﬂ  uorescence microscopy. Puriﬁ  cation of TAP-EspF was performed 
as follows: MDCK cells were lysed in 50 mM Hepes, pH 7.5, 150 mM NaCl, 
5% glycerol, 0.5% TX-100, 1.5 mM MgCl2, and 1 mM EGTA and incu-
bated with anti-ﬂ  ag M2 beads for 2 h. The beads were washed 3× 10 min 
with lysis buffer and eluted with LDS-PAGE buffer (Invitrogen). Immuno-
complexes were run down SDS-PAGE and gels were stained with Coo-
massie. Proteins were in-gel digested and analyzed with nano liquid 
chromatography tandem mass spectrometry. Acquired data was searched ESPF NUCLEATES A MEMBRANE-TRAFFICKING SIGNALING COMPLEX • ALTO ET AL. 1277
with Inspect against a dog database (National Center for Biotechnology 
Information, Canis familiaris fasta protein database). Identiﬁ  ed peptides were 
manually veriﬁ  ed to be canine SNX9: aa 218–237, S  A  A  P  Y  F  K  D  S  E  S  A  E  A  G-
G  A  Q  R  ; aa 313–327, S  Y  I  E  Y  Q  L  T  P  T  N  T  N  R  ; aa 346–359, F  G  S  A  I  P  I  P  S  L  P  D  K  ; 
aa 515–529, T  Y  E  E  I  A  G  L  V  A  E  Q  P  K  ; aa 543–557, K.G  F  L  G  C  F  P  D  I  I  G  A  H  K  .G; 
and aa 605–613, IYDYNSVIR.
Online supplemental material
Fig. S1 shows membrane tubule formation induced by EspF, and colocali-
zation of endogenous SNX9 at these sites (Fig. S1, A and B). Fig. S2 dem-
onstrates that actin is polymerized de novo at sites of EspF/SNX9 
membrane tubules. Video 1 shows dynamics of EGFP-EspF and Clc-DsRed 
in living Swiss 3T3 cells captured by TIR-FM. Video 2 shows EspF and 
clathrin dynamics at a single CCP. Video 3 shows a dynamic membrane 
tubule induced by EspF expressing at the cell surface. Video 4 demon-
strates a “rocketing” clathrin structures seemingly being propelled by EspF. 
Video 5 demonstrates a splitting clathrin structures with EspF localizing to 
the center of this event.
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